company background image
SOPH logo

SOPHiA GENETICS NasdaqGS:SOPH Rapport sur les actions

Dernier prix

US$3.64

Capitalisation boursière

US$241.0m

7D

2.0%

1Y

-5.7%

Mise à jour

04 Nov, 2024

Données

Finances de l'entreprise +

SOPHiA GENETICS SA

NasdaqGS:SOPH Rapport sur les actions

Capitalisation boursière : US$241.0m

SOPHiA GENETICS SA Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour SOPHiA GENETICS
Historique des cours de bourse
Prix actuel de l'actionUS$3.64
Plus haut sur 52 semainesUS$7.37
Plus bas sur 52 semainesUS$2.70
Bêta1.03
1Variation sur 1 mois10.64%
Variation sur 3 mois-10.34%
Variation sur 1 an-5.70%
3Variation sur 3 ans-77.25%
Variation sur 5 ansn/a
Évolution depuis l'introduction en bourse-78.28%

Nouvelles et mises à jour récentes

Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?

Oct 03
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?

Recent updates

Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?

Oct 03
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?

SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target

Aug 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target

Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)

Aug 08
Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)

SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector

Feb 12

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Nov 09
Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Aug 08
Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 15
Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies

Sep 21

SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M

Aug 09

We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

Jul 01
We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 18
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Mar 10
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Nov 24
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Rendement pour les actionnaires

SOPHUS Healthcare ServicesUS Marché
7D2.0%0.4%-1.6%
1Y-5.7%2.4%30.8%

Rendement vs Industrie: SOPH underperformed the US Healthcare Services industry which returned 2.4% over the past year.

Rendement vs marché: SOPH underperformed the US Market which returned 30.8% over the past year.

Volatilité des prix

Is SOPH's price volatile compared to industry and market?
SOPH volatility
SOPH Average Weekly Movement10.4%
Healthcare Services Industry Average Movement8.8%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Cours de l'action stable: SOPH's share price has been volatile over the past 3 months compared to the US market.

Volatilité au fil du temps: SOPH's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

À propos de l'entreprise

FondéeSalariésPDGSite web
2011430Jurgi Camblongwww.sophiagenetics.com

SOPHiA GENETICS SA est une société de technologie logicielle native dans le domaine de la santé. La société propose la plateforme SOPHiA DDM, une plateforme logicielle native pour l'analyse des données et la génération d'informations à partir d'ensembles de données multimodales et de modalités de diagnostic. Sa plateforme SOPHiA DDM et les solutions, applications, produits et services associés sont utilisés par des hôpitaux, des laboratoires et des sociétés biopharmaceutiques par l'intermédiaire de sa propre force de vente ainsi que de distributeurs et de collaborateurs industriels en Suisse, en France, en Italie, dans le reste de l'Europe, en Amérique du Nord, aux États-Unis, en Amérique latine et dans la région Asie-Pacifique.

SOPHiA GENETICS SA Résumé des fondamentaux

Comment les bénéfices et les revenus de SOPHiA GENETICS se comparent-ils à sa capitalisation boursière ?
SOPH statistiques fondamentales
Capitalisation boursièreUS$241.00m
Bénéfices(TTM)-US$66.78m
Recettes(TTM)US$64.94m

3.7x

Ratio P/S

-3.6x

Ratio P/E

Le site SOPH est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
SOPH compte de résultat (TTM)
RecettesUS$64.94m
Coût des recettesUS$20.59m
Marge bruteUS$44.35m
Autres dépensesUS$111.14m
Les revenus-US$66.78m

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

Nov 05, 2024

Résultat par action (EPS)-1.01
Marge brute68.30%
Marge bénéficiaire nette-102.84%
Ratio dettes/capitaux propres11.0%

Quelles ont été les performances à long terme de SOPH?

Voir les performances historiques et les comparaisons